Tag Archives | B2-microglobulin

Vermillion(VRML):Novel Diagnostic Tests Utilizing Biomarkers

Restructuring Play in Diagnostics at a VC Valuation Vermilion(VRML) technology utilizes a panel of biomarkers integrated with multivariate analysis software to develop disease specific assays. The R&D effort leverages collaborations with institutions such as Stanford, John Hopkins and MD Anderson for discovery and validation of biomarkers. Vermillion’s OVA 1 Test for ovarian cancer was cleared […]

Continue Reading